treatments for mds and secondary aml, with drs o. odenike and d. sallman
Published 3 years ago • 680 plays • Length 15:30Download video MP4
Download video MP3
Similar videos
-
6:13
treatments for mds and secondary aml - part 2, high-risk
-
8:11
non transplant treatments for mds & secondary aml (co-chair summary)
-
4:26
treatments for mds and secondary aml part 1, low-risk mds
-
5:36
david sallman: magrolimab plus azacitidine effective in mds and aml
-
1:13:29
understanding higher risk mds and transtion to aml
-
27:20
myelodysplastic syndromes and secondary aml: an update on diagnosis and treatment
-
1:01:45
new and emerging therapies for mds
-
1:00:54
managing higher risk mdl and aml
-
1:13
expanding treatment options for aml to patients with mds
-
1:27
the role of menin inhibitors in the treatment of hr-mds and aml
-
9:29
non-transplant treatment for mds
-
19:37
2021 west oncology app | treatment options for elderly aml/mds patients
-
3:13
what is the current treatment approach for secondary mds?
-
27:38
treatment decision-making through the spectrum of mds
-
1:55
what is supportive care for mds?
-
1:36
innovations in mds and aml treatment
-
1:32:06
high risk mds treatment strategies
-
8:25
treating aml with mds-related changes
-
2:27
what are the treatment options for mds-related anemia?